Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability*

Kuan-lin Huang(Icahn School of Medicine at Mount Sinai), Li Ding(Shenyang Agricultural University), Yi-Ting Wang(Pacific Northwest National Laboratory), Song Cao(James S. McDonnell Foundation), Kelly V. Ruggles(New York University), Michael C. Wendl(Washington University in St. Louis), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Shunqiang Li(Washington University in St. Louis), Steven A. Carr(Broad Institute), Samuel Payne(Brigham Young University), Mehdi Mesri(National Cancer Institute), Tao Liu(United States Air Force), R. Reid Townsend(Washington University in St. Louis), Tina Primeau(James S. McDonnell Foundation), Jason M. Held(Washington University in St. Louis), Yuqian Gao(Pacific Northwest National Laboratory), Matthew J. Ellis(Guardant (United States)), Sherri R. Davies(Washington University in St. Louis), David Fenyö(Institute for Systems Biology), Henry Rodriguez(Cancer Clinic), Joshua F. McMichael(Washington University in St. Louis), Kimberly Johnson(Washington University in St. Louis), Christopher R. Kinsinger(National Institutes of Health), Feng Chen(Northwestern University), Adam Scott(James S. McDonnell Foundation), Yige Wu(China Agricultural University)
Molecular & Cellular Proteomics
June 13, 2019
Cited by 19


Related Papers